Skip to search formSkip to main contentSkip to account menu

Revlimid

Known as: Celgene brand of lenalidomide, Revimid 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

lenalidomide
lenalidomide 15 MG Oral Capsule [Revlimid]lenalidomide 25 MG Oral Capsule [Revlimid]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma
In the last 10 years, major advances have been made in the diagnosis and development of selective therapies for several blood… 
Review
2011
Review
2011
A 71-year-old woman with multiple myeloma status after stem cell transplantation.
A 71-year-old woman with a 9-year history of monoclonal gammopathy of undetermined significance presented with anemia [hemoglobin… 
Highly Cited
2005
Highly Cited
2005
Immunomodulatory Drug CC-5013 or CC-4047 and Rituximab Enhance Antitumor Activity in a Severe Combined Immunodeficient Mouse Lymphoma Model
New thalidomide derivatives CC-5013 and CC-4047 (immunomodulatory drugs, IMiD) are up to 10,000 times more potent than… 
Review
2005
Review
2005
Cure of myeloma: hype or reality?
Summary:High-dose treatment (HDT) with autologous stem cell transplant(s) (ASCT) improved survival, when compared to standard… 
Highly Cited
2004
Highly Cited
2004
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
We assessed the safety, tolerability and efficacy of the immunomodulatory drug, CC-5013 (REVIMID™), in the treatment of patients… 
Review
2004
Review
2004
Clinical update: novel targets in multiple myeloma.
Novel therapies that can target the multiple myeloma (MM) cell, the MM cell-patient bone marrow interaction, and the bone marrow… 
2003
2003
Modifications to therapy for multiple myeloma: pegylated liposomal Doxorubicin in combination with vincristine, reduced-dose dexamethasone, and thalidomide.
The combination of vincristine, doxorubicin, and dexamethasone is an effective treatment for multiple myeloma that produces a… 
Review
2003
Review
2003
Potential new therapeutics for Waldenstrom's macroglobulinemia.
Thalidomide the first commercially available immune modulatory drug (IMiD), has activity in the treatment of Waldenstrom's… 
Highly Cited
2002
Highly Cited
2002
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects
The anti-tumour effects of thalidomide have been associated with its anti-angiogenic properties. Second generation thalidomide… 
Highly Cited
2002
Highly Cited
2002
Thalidomide and its analogues have distinct and opposing effects on TNF‐α and TNFR2 during co‐stimulation of both CD4+ and CD8+ T cells
Thalidomide (Thd) is clinically useful in a number of conditions where its efficacy is probably related to its anti‐TNF… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)